The purpose of this study is to determine the effect of aspirin desensitization on symptoms and immunologic profile of patients with aspirin-exacerbated respiratory diseases (AERD).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
32
Department of Allergy and Immunology, Rasool-e-Akram Hospital, Tehran University of Medical Sciences
Tehran, Tehran Province, Iran
Change in SNOT-22 scores from Baseline
At baseline and 6 months after treatment, all participants will complete the SNOT-22 questionnaire. SNOT-22 is a validated disease specific questionnaire that assesses the health related quality of life patients.
Time frame: 6 months
change in serum concentration of IL-10
At baseline and 6 months after treatment, serum level of IL-10 will be investigated for all participants.
Time frame: 6 months
change in concentration of serum TGF-beta
At baseline and 6 months after treatment, serum level of TGF-beta will be investigated for all participants
Time frame: 6 months
change in concentration of serum IFN-gamma
At baseline and 6 months after treatment, serum level of IFN-gamma will be investigated for all participants.
Time frame: 6 months
Lund Mackay score
For all participants, Lund Mackay will be scored by investigators.
Time frame: 6 months
Asthma attacks
Number of asthma attacks will be recorded for all participants over a 6-month follow up.
Time frame: 6 months
medication needs
Medication needs to relief respiratory symptoms will be recorded for all participants over a 6-month period.
Time frame: 6 months
FEV1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
FEV1 for all patients will be assessed using spirometery
Time frame: 6 months